Journals / Alpha psychiatry (Online) / 2022 / Cilt: 23 - Sayı: 3

Determination of Health Anxiety and Resilience Levels in Patients with Fibromyalgia Syndrome and Rheumatoid Arthritis During SARS-CoV-2 Pandemic: A Case–Control Study

Pages
106–112
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

But there was a positive correlation between fibromyalgia syndrome and rheumatoid arthritis groups and resilience.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: Fibromyalgia Syndrome and Rheumatoid Arthritis are chronic diseases associated with pain.
📊
Key Findings & Data:The study aimed to determine health anxiety and resilience levels in patients with fibromyalgia syndrome and rheumatoid arthritis during the severe acute respiratory syndrome coronavirus 2 pandemic.
💡
Conclusion & Impact:But there was a positive correlation between fibromyalgia syndrome and rheumatoid arthritis groups and resilience.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background: Fibromyalgia Syndrome and Rheumatoid Arthritis are chronic diseases associated with pain. These diseases reduce the patient’s quality of life and cause psychological problems. The study aimed to determine health anxiety and resilience levels in patients with fibromyalgia syndrome and rheumatoid arthritis during the severe acute respiratory syndrome coronavirus 2 pandemic. Methods: This case–control study conducted in Central Anatolia Region, Turkey, included 180 participants (60 patients with fibromyalgia syndrome, 60 patients with rheumatoid arthritis, and 60 healthy subjects). Data were collected using the Brief Resilience Scale and Health Anxiety Scale. Pain intensity was assessed using the Visual Analog Scale. Results: Resilience was significantly higher in healthy controls than in the fibromyalgia syndrome and rheumatoid arthritis groups (P < .001). Resilience was also higher in the rheumatoid arthritis group than fibromyalgia syndrome (P < .001) group. Hypersensitivity to somatic symptoms and anxiety, negative results of diseases, and total scores of Health Anxiety Scale were significantly higher in the fibromyalgia syndrome and rheumatoid arthritis groups than healthy controls (P < .001). Also, Health Anxiety Scale scores in the fibromyalgia syndrome group were higher than the rheumatoid arthritis group (P < .001). There was a very strong and negative correlation between the participants’ resilience and health anxiety levels (r = -0.818, P < .001). The most important predictors of resilience were hypersensitivity to somatic symptoms and anxiety (r = -0.335, P < .001), the group (r = 0.302, P = .003), the pain intensity (r = -0.169, P = .043), and the negative consequences of the disease (r = -.149, P = .038). The hypersensitivity to somatic symptoms and anxiety, the Visual Analog Scale, and the negative consequences of the disease were negatively correlated with resilience. But there was a positive correlation between fibromyalgia syndrome and rheumatoid arthritis groups and resilience.

🔖

Cite This Article

YILMAZ, E. B., YÜKSEL, A., KARAKOYUN, A. (2022). Determination of Health Anxiety and Resilience Levels in Patients with Fibromyalgia Syndrome and Rheumatoid Arthritis During SARS-CoV-2 Pandemic: A Case–Control Study. Alpha psychiatry (Online), Cilt: 23 - Sayı: 3, 106–112. https://ajindex.com/articles/435163

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Hedman-Lagerlöf E, Tyrer P, Hague J, Tyrer H. Health anxiety. BMJ. 2019
  2. l774. [CrossRef] 2. Lebel S, Mutsaers B, Tomei C, et al. Health anxiety and illness-related fears across diverse chronic illnesses: a systematic review on conceptualization, measurement, prevalence, course, and correlates. PLoS One. 2020
  3. 15(7):e0234124. [CrossRef] 3. Karahroodi SG, Azar FS. Comparison of health anxiety, sleep and life quality in people with and without chronic pain. J Anesthesiol Pain. 2020
  4. 10(4):63-76. 4. Rachor GS, Penney AM. Exploring metacognitions in health anxiety and chronic pain: a cross-sectional survey. BMC Psychol. 2020
  5. 8(1):81. [CrossRef] 5. Sarzi-Puttini P, Salaffi F, Di Franco M, et al. Pain in rheumatoid arthritis: a critical review. Reumatismo. 2014
  6. 66(1):18-27. [CrossRef] 6. Siracusa R, Di Paola RD, Cuzzocrea S, Impellizzeri D. Fibromyalgia: pathogenesis, mechanisms, diagnosis and treatment options update. Int J Mol Sci. 2021
  7. 22(8):3891. [CrossRef] 7. Yeung EW, Arewasıkporn A, Zautra AJ. Resilience and chronic pain. J Soc Clin Psychol. 2012
  8. 31(6):593-617. [CrossRef] 8. Ramírez-Maestre C, de la Vega R, Sturgeon JA, Peters M. Editorial: Resilience resources in chronic pain patients: the path to adaptation. Front Psychol. 2019
  9. [CrossRef] 9. Soriano J, Monsalve V. Profiles of personality and resilience in chronic pain: utility of the CD-RISC-10 to discriminate between resilient and vulnerable types. Rev Soc Esp Dolor. 2019
  10. 26(2):72-80. 10. Slepian PM, Ankawi B, Himawan LK, France CR. Development and initial validation of the pain resilience scale. J Pain. 2016
  11. 17(4):462-472. [CrossRef] 11. Doğan T. Adaptation of the Brief Resilience Scale into Turkish: a validity and reliability. The J Happiness Well-Being. 2015
  12. 3(1):93-102. 12. Salkovskis PM, Rimes KA, Warwick HM, Clark DM. The Health Anxiety Inventory: development and validation of scales for the measurement of health anxiety and hypochondriasis. Psychol Med. 2002
  13. 32(5):843-853. [CrossRef] 13. Aydemir Ö, Kırpınar İ, Satı T, Uykur B, Cengisiz C. Reliability and validity of the Turkish version of the health anxiety inventory. Noro Psikiyatr Ars. 2013
  14. 50(4):325-331. [CrossRef] 14. Mohabbat AB, Mohabbat NML, Wight EC. Fibromyalgia and chronic fatigue syndrome in the age of COVID-19. Mayo Clin Proc Innov Qual Outcomes. 2020
  15. 4(6):764-766. [CrossRef] 15. Kharko AY, Hansford KJ, Furlong PL, Hall SD, Roser ME. The anxiety and pain of fibromyalgia patients during the COVID-19 pandemic. medRxiv. 202